Jazz Pharmaceuticals (JAZZ) Acquisitions (2012 - 2014)
Jazz Pharmaceuticals' (JAZZ) quarterly Acquisitions came in at $828.7 million in Q1 2014, up 32.74% quarter-over-quarter from $624.3 million in Q2 2012.
Jazz Pharmaceuticals (JAZZ) Acquisitions (2012 - 2014) Analysis & Trends
Jazz Pharmaceuticals' Acquisitions history runs 2 years deep, the most recent figure standing at $828.7 million for Q1 2014.
- On a quarterly basis, Acquisitions changed N/A year-over-year to $828.7 million in Q1 2014; TTM through Dec 2014 was $828.7 million, a N/A change from a year earlier, with the FY2021 full-year figure at $6.2 billion, changed N/A from the prior year.
- Acquisitions grew to $828.7 million in Q1 2014 per JAZZ's latest filing, from $624.3 million in the prior quarter.
- Across five years, Acquisitions topped out at $828.7 million in Q1 2014 and bottomed at -$81.8 million in Q1 2012.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Jazz Pharmaceuticals | 15.78 Bn | 13.93 Bn | 934.80 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2014 | 828.68 Mn |
| Jun 30, 2012 | 624.28 Mn |
| Mar 31, 2012 | -81.75 Mn |